32-year-old actress and singer Selena Gomez became arguably the most talked-about guest at the Screen Actors Guild Awards, which took place recently in Los Angeles.

The star graced the red carpet in a custom Celine gown inspired by Old Hollywood, paired with Jimmy Choo shoes and Messika jewelry.

 

Посмотреть эту публикацию в Instagram

 

Публикация от Femme Fatale (@onparledemode)

However, what drew even more attention was Gomez’s figure — she looked significantly slimmer than just a few weeks ago. Some fans speculated that Selena might have joined the wave of Ozempic users to lose weight. Others reminded that she suffers from lupus, which led to a kidney transplant. It’s entirely possible that new health issues contributed to her weight loss.

 

Посмотреть эту публикацию в Instagram

 

Публикация от Just Jared (@justjared)

Meanwhile, other social media users believe that Selena simply went on a strict diet to shed weight quickly for awards season and its grand finale — the Oscars. Additionally, the singer is set to marry her fiancé, Benny Blanco, this year, which could also be a motivation for working on her appearance.

For reference, here’s how Selena looked just a week ago at the BAFTA Awards.

 

Посмотреть эту публикацию в Instagram

 

Публикация от Just Jared (@justjared)

The 53-year-old tech mogul Elon Musk knows how to surprise the public. This time, it’s not another humanoid robot or a SpaceX rocket launch, but his own weight loss. The billionaire posted a photo on Platform X, where he looks noticeably slimmer, posing by a Christmas tree with gifts, dressed in a Santa Claus costume.

«Ozempic Santa,» Musk captioned the post, which sparked lively discussions among his followers.

However, he soon clarified that he actually used a different drug — Mounjaro. According to the entrepreneur, Ozempic had numerous side effects. Compared to it, Mounjaro turned out to be more effective — though not without its own unpleasant consequences.

It’s worth noting that, like Ozempic, Mounjaro is a drug designed to help people with diabetes regulate blood sugar and insulin levels.

In November 2023, the FDA approved Mounjaro under the trade name Zepbound as a weight management drug for those struggling with excess weight or obesity.

Photo: x.com/elonmusk